If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

SensiumVitals® expands distribution network

26 Mar 2014 07:00

RNS Number : 1876D
Toumaz Limited
26 March 2014
 



 

RNS REACH

26 March 2014

 

Toumaz Limited

SensiumVitals® expands international distribution network

Toumaz Limited (AIM: TMZ, 'Toumaz', or 'the Group'), a pioneer in ultra-low power wireless semiconductor technology, announces that Sensium Healthcare, its wireless healthcare division, has extended the sales reach of its SensiumVitals® vital signs monitor to 12 countries.

Sensium Healthcare has recruited its own highly experienced direct sales force in the UK, France and Germany. The company has also executed distribution agreements for another four territories in Scandinavia (Sweden, Norway and Denmark) and the Middle East (Bahrain).

Along with existing agreements in the USA, Canada, Mexico, Australia and New Zealand, SensiumVitals® now has distribution in countries which collectively account for 60% of global healthcare spend. The company has also received regulatory clearance for SensiumVitals® in Australia.

With this development of its sales and distribution networks, Sensium Healthcare is embarking on full commercialisation of the SensiumVitals® system. The company is currently in discussions with over 60 hospitals worldwide.

Anthony Sethill, CEO of Toumaz Group, said:

"In the last six months, we have established an experienced and highly effective international sales platform for SensiumVitals®.

Initial customer engagements have been very encouraging. SensiumVitals® is positioned as a "game changer" for patient safety and healthcare economics - and it is proving a compelling proposition with both clinicians and hospital managers.

In 2014, we expect a significant ramp up in Sensium Healthcare's revenues - as discussions already under way with hospitals in Europe, North America and Australia lead to deployments in all of those regions."

Enquiries:

Toumaz Limited

+44 (0)20 7391 0630

Anthony Sethill, Chief Executive Officer

Jonathan Apps, Chief Financial Officer

Instinctif Partners

+44 (0)20 7457 2056

Adrian Duffield/Rozi Morris/Kathy Gordon

About Toumaz (www.toumaz.com)

Toumaz Limited is a pioneer in low-power, wireless semiconductor and software technologies for healthcare and consumer audio. The Group has two divisions, Sensium Healthcare and Frontier Silicon. Sensium Healthcare develops wireless solutions for patient monitoring. Frontier Silicon provides chip, modules and software for digital radio and connected audio devices.

About SensiumVitals®

SensiumVitals® is an ultra-low power system for wireless monitoring of patient vital signs, including heart rate, temperature and respiration. Measurements are taken every two minutes, rather than every four to eight hours, as currently standard in general wards. Patient data is then sent wirelessly and securely to clinicians via hospital IT systems. 

The key benefit of SensiumVitals® is that it provides clinicians with rapid warnings of patient deterioration, which in turn allows for earlier interventions, shorter stays in hospital and lower healthcare costs. 

For more information, see http://www.sensium-healthcare.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRASEIFUIFLSEID
Date   Source Headline
20th Feb 201210:16 amRNSHolding(s) in Company
16th Feb 20127:00 amRNSCompletion of placing
13th Feb 20127:00 amRNSTrading update
13th Feb 20127:00 amRNSPlacing raises £11.2m
3rd Jan 20127:00 amRNSSubsidiary established with Imagination Technologi
24th Oct 20117:00 amRNSTelran distribution clearance
21st Sep 20117:00 amRNSHalf year results
9th Aug 20114:52 pmRNSNotice of Results
29th Jul 20117:00 amRNSHalf year trading update
11th Jul 20117:00 amRNSFDA approval for Sensium
11th Jul 20117:00 amRNSJV established with CCE
5th May 20115:24 pmRNSResult of AGM
29th Mar 20117:00 amRNSFull year results
16th Mar 20113:16 pmRNSNotice of Results
16th Mar 20113:05 pmRNSHolding(s) in Company
3rd Mar 20114:34 pmRNSIssue of Equity
2nd Mar 20118:14 amRNS£1.8m Raised
10th Feb 20117:41 amRNSStrategic Investment
1st Feb 20117:00 amRNSYear End Trading Update
1st Feb 20117:00 amRNSTELRAN Launch
30th Nov 20107:00 amRNSXENIF processor in production
15th Sep 20107:00 amRNSInterim Results
24th Aug 20109:33 amRNSIssue of Equity
11th Aug 201011:52 amRNSNotice of Results
27th Jul 20107:00 amRNSLicense agreement
15th Jul 201010:19 amRNSIssue of Equity and Exercise of Options
30th Jun 20107:00 amRNSTrading Update
16th Jun 20108:49 amRNSAnnual Financial Report
26th May 20109:07 amRNSChange of Name
10th May 20102:52 pmRNSResult of AGM
30th Mar 20107:00 amRNSFinal Results
12th Mar 20109:00 amRNSQuanta takes strategic stake
11th Mar 20104:27 pmRNSDirector dealings
10th Mar 201011:26 amRNSNotice of Results
23rd Feb 20107:00 amRNSClinical Trial Update
1st Feb 20102:02 pmRNSExercise of Options - replacement
29th Jan 201012:33 pmRNSExercise of Options
22nd Dec 200911:19 amRNSHolding(s) in Company
21st Dec 20097:00 amRNSHolding(s) in Company
17th Dec 20093:10 pmPRNResult of EGM
14th Dec 20093:34 pmPRNDirector/PDMR Shareholding
1st Dec 20097:00 amPRNProposed Placing and Update
9th Nov 20091:20 pmRNSNational Microelectronics Institute Award
2nd Nov 20097:00 amPRNSensium Digital Plaster European Trial
28th Sep 20097:00 amPRNHalf-yearly Report
22nd Sep 200912:16 pmRNSHolding(s) in Company
11th Sep 20097:00 amRNSCorrection re holding in company
10th Sep 20097:00 amRNSHolding(s) in Company
7th Aug 200912:01 pmRNSHolding(s) in Company
22nd Jul 200911:21 amPRNResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.